Home > News > Protiveris Received MIPS Award for Technology Optimization
April 1st, 2004
Protiveris Received MIPS Award for Technology Optimization
Protiveris Inc., a bio- nanotechnology company commercializing bioMEMS technologies to facilitate protein research and the discovery of new pharmaceuticals, today announced that it is a recipient of a $116,000 award from the Maryland Industrial Partnerships (MIPS) program. This award is to be used for the optimization of microfluidic sample delivery system in the VeriScan(TM) 3000 -- the Company's patent pending biosensor system for advanced biological and chemical detection.
Arrowhead to Present at 2015 RBC Capital Markets' Global Healthcare Conference February 17th, 2015
Iran 1st among Islamic Nations in Scientific Production, Nanotechnology February 16th, 2015
Harris & Harris Group Portfolio Company D-Wave Systems Raises an Additional $29 Million (CAD), Closing 2014 Financing at $62 Million (CAD) February 2nd, 2015
Malaysian Nanotechnology Company Nanopac Innovation Ltd. lists on the NSX January 19th, 2015